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The study was conducted with the objective of examining the outer membrane proteins and their 
involvement during the transport of  - lactams in multidrug resistant Escherichia coli  isolated from 
extra-intestinal infections. Also, the response of gram negative bacterial biomembrane alteration was 
studied using extended spectrum -Lactamase (ESBL) positive strains of E.coli in the presence and 
absence of stress. Outer membrane protein analysis revealed that multidrug resistance was mediated 
by loss of porins in the ESBL isolates of E. coli. Parallel to this, the level of outer membrane proteins 
decreased dramatically with increased antibiotic stress in the isolates. In non-ESBL isolates of E. coli, 
porins seems to have no influence in co-modulation of resistance. 
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Membrane permeability is the first step involved in resis-
tance of bacteria to an antibiotic. The outer membrane 
proteins that constitute porins play major roles in the 
definition of intrinsic resistance in gram-negative bacteria 
that is altered under antibiotic exposure (Viveiros et al., 
2007). Outer membrane proteins (OMPs) of gram-
negative bacteria have diverse functions. They are 
directly involved in the interaction with various environ-
ments encountered by pathogenic organisms. Thus, 
OMPs represent important virulence factors and play 
essential roles in bacterial adaptation to host niches, 
which are usually hostile to invading pathogens 
(Martínez-Martínez, 2008). Porins are outer membrane 
proteins that form water-filled channels that permit the 
diffusion of small hydrophilic solutes like -lactam anti-
biotics across the outer membrane (Nikaido et al., 1983; 
Varadhachary and Maloney, 1990; Martinez-Martinez et 
al., 2002). Two major porins that facilitate diffusion of 
antimicrobials have been described in Escherichia coli 
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al., 2006). The decrease of OmpC and OmpF appears to 
result from their being degraded by proteases as long as 
the activity of genes that code for these proteins are also 
significantly elevated during prolonged antibiotic stress 
(Viveiros et al., 2007). Since -lactam antibiotics 
penetrate the outer membrane of gram-negative bacteria, 
resistance could also be caused by loss or deficiency of 
specific porins that reduce the outer membrane 
permeability to -lactam antibiotic (Ananthan and Subba, 
2005). This might be an important factor in mediating -
lactam resistance in multidrug resistant E. coli in ESBL 
and non-ESBL isolates. It has been noted that the 
response to prolonged exposure to increasing levels of 
antibiotic cause major changes in the permeability of the 
bacterium due to over-expression of efflux pumps and 
down-regulation of porins (Bradford, 2001; Nikaido, 
2003).  
Cephalosporins enter the cell through OmpC and 
OmpF porin in the strains of E.coli. Proteomic studies 
indicate that OmpC is an important outer membrane 
protein for tetracycline resistance in E. coli (Zhang et al., 
2008).  OmpC forms trimeric porin allowing ions and 
other hydrophilic solutes to cross the outer membrane 
(Neidhart and Curtiss, 1996). The solutes tend to be less 
than   500  daltons.   OmpC  is  tightly  but  noncovalently  
                




Table 1. Phenotypes of E. coli strains isolated from extra-intestinal infections (N= 80). 
 
Phenotype Phenotype detected with 
Cefotaxime1 Ceftazidime2 Both antibiotics3 
Presumptive ESBL producers 29 (36.25%) 32 (40%) 26 (32.5%) 
Confirmed ESBL producers 21 (26.25%) 24 (30%) 18 (22.5%) 
 
1Phenotype detected with cefotaxime but not with ceftazidime.  
2Phenotype detected with ceftazidime but not with cefotaxime.  




associated with the peptidoglycan layer (Lambert, 1988). 
Also, OmpF allows the passage of solutes such as 
sugars, ions, and amino acids which are less than 600 
daltons, with a weak preference for cationic molecules 
(Cowan et al., 1992). This suggests that these two porins 
are crucial for entry into survival mode (Darcan et al., 
2003). 
In the present study the presence of porin mediated 
resistance to -lactam antibiotics in ESBL producing and 
non-producing strains in multidrug resistant E. coli 
recovered from persons suffering from extra-intestinal 
infections was examined.  
 
 
MATERIALS AND METHODS 
 
A total of 80 isolates of E.coli from extra-intestinal infections were 
obtained between July 2008 and September 2008 from hospital of 
Pune (India). Isolates collected were from the urine, pus and 
sputum and were processed immediately using standard proce-
dures. The isolates were identified based on colony morphology on 
blood agar, MacConkey's agar, gram staining and by standard 
biochemical tests (Crichton, 1996). Reference strain of E. coli 113-
D was obtained from National Collection of Industrial Micro-
organisms (NCIM), Pune. 
Screening for ESBL production was done according to criteria 
recommended by National Committee for Clinical Laboratory 
Standards (NCCLS). Two discs, ceftazidime (30 µg) and cefotaxime 
(30 µg), were used for in vitro sensitivity testing by Kirby-Bauer disc 
diffusion method (1966). For phenotypic confirmatory testing, 
ceftazidime (30 g) vs. ceftazidime/clavulanic acid (30/10 g) and 
cefotaxime (30 g) vs. cefotaxime/clavulanic acid (30/10 g) were 
placed onto Mueller Hinton agar plate lawned with the test 
organisms incubated overnight at 37 °C for 20 h. An increase in 
zone of inhibition greater than 5 mm of an antimicrobial agent 
tested in combination with clavulanic acid vs. its zone size when 
tested alone, indicated ESBL production (NCCLS, 2002, CLSI 
2006).  
The sensitivity of the isolates to third generation cephalosporins 
(3GC) viz., ampicillin (10 g), co-trimoxazole (30 g), cefotaxime 
(30 g), ciprofloxacin (30 g), ceftriaxone (30 g), ceftazidime(30 
g), imipenem (30 g). (Hi-Media, India) was determined by the 
disc diffusion method. The results were interpreted as per National 
Committee for Clinical Laboratory Standards recommendations 
(NCCLS, 2002, CLSI, 2006).  
Konnings and Kaback (1973) procedure was used for preparation 
of OMP’s with few modifications. The OMP profile was analysed by 
polyacrylamide gel elecrophoresis (30% acrylamide/0.8% bis-
acrylamide, 20% SDS). Gels were visualized by staining with 
coomassie blue (Sigma). 
RESULTS AND DISCUSSION 
 
The ESBL phenotypic screening by double disc diffusion 
synergy test showed that the maximum number of ESBL 
producing E. coli 17 (94.4%) were isolated from urine. 
Out of 80 clinical isolates, 26 (32.5%) were positive for 
ESBL by screening test, 18 (22.5%) were positive by 
confirmatory test for ESBL, whereas all the 54 isolates 
that were negative by screening were also negative by 
confirmatory test. These results were consistent with 
previous studies (Joumana and Araj, 2003; Hong et al., 
2004; Sharma et al., 2007) (Table 1). 
Antibiotic susceptibility pattern was studied for all 
isolates of E. coli. 100% resistance was observed to 
ciprofloxacin, co-trimoxazole followed by 58.7% to 
ampicillin in the isolates. The prevalence of resistance to 
common antibiotics has also been reported earlier 
(Wiener et al., 1999; Chitnis et al., 2003; Ajith, 2006). All 
isolates were sensitive to ceftazidime and imipenem. 
These results were consistent with the previous studies 
on drug resistance in E. coli (Naoki and Shinzaburo, 
1999; Rupal et al., 2007). It has been reported earlier that 
ESBLs are capable of hydrolyzing broad spectrum 
cephalosporins and monobactams but inactive against 
cephamycins and imipenem (Chaudhary and Aggarwal, 
2004). In this study, the levels of sensitivities to various 
antimicrobial drugs commonly used for treatment were 
compared (Table 2). The isolates showed reduced 
susceptibility to cefotaxime and ceftriaxone as compared 
to other cephalosporins. However, cefotaxime was found 
to be more active than ceftriaxone. In addition, the 
susceptibility pattern was not similar for ESBL and non-
ESBL isolates (Table 2). In another study using Neisseria 
meningitidis , it was found that on the basis of the 
minimum inhibitory concentrations (MICs), ceftriaxone 
was found to be more active than cefotaxime (cefotaxime 
MIC90, 0.007 µg/ml;
 ceftriaxone MIC90, 0.0015 µg/ml) 
(Arreaza et.al., 2000). 
OMP profile showed the absence of 35 kDa porin 
protein in ESBL- positive isolate of  E. coli (ampicillin R, 
cefotaxime I) (Figure 1) in the presence as well as absence 
of stress . Loss of porins) contributes to antimicrobial 
resistance, particularly when additional mechanisms of 
resistance were expressed. The study shows that the 
membrane proteins  got  affected  by  -lactam  transport 
                




Table 2. Antimicrobial susceptibility pattern of ESBL and non ESBL clinical isolates of E. coli. 
 
S/N Antibiotic ESBL positive isolates of E. coli (n= 18) Non ESBL isolates of E. coli (n= 62) 
Resistant Intermediate Sensitive Resistant Intermediate Sensitive 
1 Ampicillin 17 (94.4%) 1 (5.5%) - 30 (48.3%) 32 (51.6%) - 
2 Co-trimoxazole 18 (100% - - 62 (100%) - - 
3 Ciprofloxacin 18 (100%) - - 62 (100%) - - 
4 Ceftriaxone - 3 (16.4%) 15 (83.3%) - 30 (48.4%) 32 (51.6%) 
5 Cefotaxime - 1(5.6%) 17 (94.4%) - 29 (46.8%) 33 (53.2%) 
6 Ceftazidime - - 18 (100%) - - 62 (100%) 






Figure 1. The OMP profile was studied for well 
characterized strains. Lane M: Marker protein. Lane 1: 
Reference strain (E.coli 113-D). Lane 2: ESBL positive 
(ampicillin R, cefotaxime I) without cefotaxime stress. Lane 
3: ESBL positive (ampicillin R ,cefotaxime I) with 
cefotaxime stress. Lane 4 : ESBL- negative, (ampicillin I 
,cefotaxime S) without cefotaxime stress. Lane 5: ESBL 




revealing the mediation of direct antibiotic protein inte-
raction. Many studies on the structure and regulation of 
porins in E. coli are available, but there is little information 
concerning clinical isolates of this species.  It has been 
reported earlier that in Klebsiella pneumoniae, two major 
porins, OmpK35 and OmpK36, were produced, but many 
extended-spectrum -lactamase (ESBL)-producing 
K. pneumoniae isolates do not express OmpK35 
(Domenech-Sanchez et al., 1999). Loss of both OmpK35 
and OmpK36 in ESBL-producing K. pneumoniae causes 
resistance to cefoxitin, increased resistance to expanded-
spectrum cephalosporins, and decreased susceptibility to 
carbapenems, particularly ertapenem (Perez et al., 
2007).  Porin loss also decreases the susceptibility to 
other non--lactam compounds, such as fluoroquino-
lones of ESBL-producing organisms (Jacoby and Han, 
1996; Livermore, 1998). 
All isolates which showed multidrug resistance, do not 
show loss of outer membrane proteins (Figure 1, Lane 4 
and 5). In non-ESBL isolates (cefotaxime S), the porins 
were found intact confirming the susceptibility of cefo-
taxime towards these clinical strains. From the OMP 
profile, there is a clear indication that the resistance to 
cefotaxime was due to both porin and ESBL mediated 
resistance. ESBLs are not active against imipenems, and 
94.4% strains expressing ESBLs are susceptible to 
cefotaxime. However, ESBL producing strains might be 
resistant to ampicillin and cefotaxime due to the loss of 
outer membrane porin protein (Figure 1, lane 2 and 3). 
Loss of porins in E. coli was found to augment resistance 
provided by ESBLs to include resistance to cefotaxime, 
oxyimino- -lactams. Reduced permeability of E. coli 
isolates due to porin loss was found to increase the MIC 
of cefotaxime. This is consistent with the findings of 
Rasheed et al., (2000) and Laura, (2006). 
Recently, cefotaximase (CTX-M) enzymes have been 
recognized in a number of focal outbreaks from many 
parts of the world, for instance in Japan (Toho-2) 45, 
India (CTX-M-15) 46 and UK 47, suggesting their wide 
dispersal that preferentially hydrolyzes cefotaxime. 
CTXM- 15 has also been found in Indian E. coli and K. 
pneumoniae strains (Medeiros, 1997). Deficiency in 
expression of an outer membrane protein (OmpK35) was 
also observed. These observations led us to postulate 
that the extremely low level of OmpK35 expression and 
the co-existence of Tumor endothelial marker 1 (TEM-1) 
and Suid herpes virus1 (SHV-1) resulted in an increased 
MIC of cefotaxime and the false designation of the isolates 
as ESBL producers (Tsu-Lan et al., 2001).  Alteration of 
Omps, especially the loss of OmpK35 when OmpK36 is 
present, can result in an increase in the MIC of 
cefotaxime to 4 mg/L. Possibly the combination of 
decreased outer membrane permeability  and  the  hydro- 
                




lytic effect of TEM-1 and SHV-1 ß-lactamases increased 
the MIC of cefotaxime slightly (Domenech-Sanchez, 
1999). 
In the ESBL isolates of E. coli, there was an elevated 
level of ampicillin resistance which resulted from a 
combination of increased enzyme production and OMP 
changes. The relatively low rates of cefotaxime coresis-
tance provided indirect evidence that 36-kDa OMP loss 
may play an important role in the expression of cefo-
taxime resistance in ESBL strains. In K. pneumoniae, 
cefoxitin resistance due to reduced permeability of porins 
to -lactam antibiotics has been reported (Ananthan and 
Subha, 2005). In the present study, the loss of porins in 
ESBL isolates shows the direct involvement of outer 
membrane components in developing resistance towards 
-lactams. 
In conclusion, knowledge of the resistance mecha-
nisms in these clinical isolates will provide data on multi-
drug resistant pathogens which would be helpful in 
making recommendations on the best use of antibiotics 
and to formulate therapeutic strategies to control infec-
tions. More prudent use of antibiotics and control of the 
spread of these resistant organisms are necessary. 
Understanding the role of bacterial OMPs in transport of 
-lactams will facilitate the design of antimicrobial drugs 
and vaccines. However, the porin-mediated mechanism 
is important in the virulence and drug-resistance of patho-
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